Edwards Lifesciences (EWL) Ownership - Who Owns Edwards Lifesciences?
Edwards Lifesciences (EWL) Ownership Overview
- 0.20% Insiders
- 23.60% Mutual Funds
- 5.02% Other Institutional Investors
- 27.17% ETFs
- 44.01% Public Companies and Individual Investors
The ownership structure of Edwards Lifesciences (DE:EWL) stock is a mix of institutional, retail, and individual investors. Approximately 55.79% of the company’s stock is owned by Institutional Investors, 0.20% is owned by Insiders, and 44.01% is owned by Public Companies and Individual Investors.
The ownership structure of Edwards Lifesciences (DE:EWL) stock is a mix of institutional, retail, and individual investors. Approximately 55.79% of the company’s stock is owned by Institutional Investors, 0.20% is owned by Insiders, and 44.01% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 30, 2026 | Andrew M. Dahl | $49,531 | |
| Aug 27, 2026 | Annette Bruls | $237,907 | |
| Aug 25, 2026 | Daveen Chopra | $2,894,371 | |
| Aug 25, 2026 | Wayne Markowitz | $113,410 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Manning & Napier Advisors Llc | €1,960 | |
| Dec 31, 2025 | Howard Hughes Medical Institute | €10,741 | |
| Dec 31, 2025 | Entrypoint Capital, Llc | €444,749 | |
| Dec 31, 2025 | Suncoast Equity Management | €1,122,145 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 62,391,825 | Institution | 10.82% | 5,837,815,890 |
| Vanguard Index Funds | 56,234,605 | Institution | 9.76% | 5,261,703,286 |
| Ishares | 35,701,933 | Institution | 6.19% | 3,340,522,765 |
| Spdr | 23,299,401 | Institution | 4.04% | 2,180,055,053 |
| Vanguard Specialized Funds | 11,846,601 | Institution | 2.06% | 1,108,450,916 |
| Fidelity Concord Street Trust | 10,030,851 | Institution | 1.74% | 938,556,636 |
| Jpmorgan | 7,188,703 | Institution | 1.25% | 672,625,374 |
| Invesco | 6,010,661 | Institution | 1.04% | 562,399,518 |
| Ubs | 4,875,535 | Institution | 0.85% | 456,189,183 |
| Jpmorgan Trust I | 4,808,758 | Institution | 0.83% | 449,941,060 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 56,234,605 | Institution | 9.76% | 5,261,703,286 |
| Vanguard Specialized Funds | 11,846,601 | Institution | 2.06% | 1,108,450,916 |
| Fidelity Concord Street Trust | 10,030,851 | Institution | 1.74% | 938,556,636 |
| Jpmorgan Trust I | 4,808,758 | Institution | 0.83% | 449,941,060 |
| Vanguard Institutional Index Funds | 3,401,475 | Institution | 0.59% | 318,265,811 |
| Vanguard Windsor Funds | 3,121,221 | Institution | 0.54% | 292,043,285 |
| Fidelity Salem Street Trust | 2,966,483 | Institution | 0.51% | 277,564,915 |
| Ivy Funds | 2,892,770 | Institution | 0.50% | 270,667,811 |
| Tiaa-cref Funds | 2,603,897 | Institution | 0.45% | 243,638,831 |
| Neuberger Berman Equity Funds | 2,289,707 | Institution | 0.40% | 214,241,015 |
FAQ
Who Owns Edwards Lifesciences (DE:EWL)?
According to the latest TipRanks data, approximately 55.79% of the company's stock is held by institutional investors, 0.20% is held by insiders, and 44.01% is held by public companies and individual investors.
What percentage of Edwards Lifesciences (DE:EWL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 55.79% of Edwards Lifesciences (DE:EWL) stock is held by institutional investors: 23.60% by mutual funds, 27.17% by ETFs and 5.02% by other institutional investors.
What percentage of Edwards Lifesciences (DE:EWL) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.01% of Edwards Lifesciences (DE:EWL) stock is held by public companies and individual investors.
Who owns the most shares of Edwards Lifesciences (DE:EWL)?
Vanguard owns the most shares of Edwards Lifesciences (DE:EWL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.